PFAS without borders: how multinationals are managing chemical compliance across 40+ jurisdictions

PFAS compliance has become a bigger problem than most in-house teams were sized to solve. While many regulatory affairs teams have major frameworks such as the US TSCA or EU REACH covered, gaps continue to open up as regulators worldwide increase their actions on PFAS. A revision to South Korea’s K-REACH substance list. An update to Australia’s PFAS assessment requirements. With a team of two, a quarterly spreadsheet, and a manual approach to monitoring, updates like these often go unnoticed until the next review cycle. By then, the window to translate changes into actionable product compliance requirements has already closed.  

This is a version of PFAS compliance that once worked. A task-based approach that is now falling behind. 

The problem has grown because the PFAS regulatory landscape is evolving faster than manual monitoring can track. At its core, this is a structural issue, not one of resources or competence. The reality for multinationals managing PFAS compliance across multiple jurisdictions is that PFAS regulation is no longer developing through a handful of high-profile frameworks moving in rough alignment. It is now shaped by regulatory activity across dozens of jurisdictions, with divergent timelines, substance lists, and thresholds. 

Why having the major frameworks covered is not enough

Having US TSCA or EU REACH covered is not the same as having PFAS compliance covered. Regulatory authorities across dozens of jurisdictions are now forging ahead with their own PFAS programs, each with its own substance scope and threshold logic, and timeline. They are not moving in alignment. The major frameworks are the just starting point, but they are not the full picture – as PFAS regulation continues to fragment across jurisdictions and topic areas.  

US  

Federal PFAS regulation is actively shifting across multiple tracks. TSCA reporting obligations, drinking water standards under the Safe Drinking Water Act, and CERCLA liability are each moving independently. But the increased complexity for many compliance teams is coming from the state level. California, Maine, and Minnesota have moved ahead of the federal timeline on several fronts, and the state-level patchwork for PFAS compliance is expanding. A compliance program built around federal requirements alone already has gaps. 

EU 

The EU’s universal PFAS restriction is progressing toward formal adoption, with ECHA’s scientific committees due to finalize opinions by end of 2026. But EU-level regulation is not the whole European picture among member states. France and Denmark have, for example, introduced their own national PFAS measures, adding another layer of variation for teams operating across European markets.  

UK  

When the UK left the EU, it carried EU REACH with it as the basis for its own chemicals regulation. The two frameworks have been diverging since, and the UK is running its own PFAS assessment process on its own timeline, often far delayed behind their EU counterpart. For teams that previously monitored one EU framework, there are now two distinct compliance programs to track.  

APAC and the Americas 

There is no single APAC PFAS framework. Australia’s AICIS, South Korea’s K-REACH, Japan’s Class I Specified Chemical Substances regime, and China’s MEE chemical regulation are each advancing independently, on different substance scopes and different schedules. The practical consequence is that each market requires separate monitoring, and updates arrive without reference to what is moving elsewhere. The same pattern is extending into the Americas. Canada is advancing PFAS regulation under CEPA on its own timeline, and regulatory activity is building in Latin American markets. For multinationals with exposure across these regions, the monitoring gap is already open. 

PFAS regulatory activity: a snapshot across jurisdictions 

Across a cross-section of jurisdictions, PFAS regulations are developing simultaneously, on different timelines and at different stages of adoption. The selection below illustrates the range. It is not exhaustive. 

The DIY monitoring problem: the three gaps  

Even the most well-run manual PFAS monitoring program is still running compliance as a task. That architecture runs into three structural gaps when faced with the level of divergent regulatory developments it now must track.   

Coverage lag 

There is a delay in its workflow between the moment a regulation changes or is published, and the moment it is detected, reviewed, and actioned. A quarterly review cycle was sufficient when regulatory changes developed more slowly. However, the PFAS regulatory landscape does not move slowly. Regulatory complexity is only increasing. The earlier a compliance team can detect a change, the more time it has to assess it, prepare a response, and avoid being caught out. Manual monitoring shortens the lead time teams have to act.  

The interpretation gap 

Finding out that a regulation has changed is not the same as knowing what to do about it. A PFAS update published in a language the compliance team doesn’t work in requires more than translation. Understanding what it materially means for a specific substance portfolio requires toxicology depth and jurisdiction-specific legal expertise to interpret it. Most DIY monitoring stops at the text. The interpretation, including what changed, what it means, and what it requires, is left uncovered.  

Substance list divergence 

PFAS is not one substance, it is a class of thousands, and no two regulatory frameworks align. The EU universal restriction covers a different subset than US EPA TSCA scope. K-REACH covers a different subset again. A substance that falls outside one framework’s scope may be regulated under another. Teams maintaining these lists manually are not just doing more work. They are managing overlapping inventories where the gaps between them are invisible until something goes wrong. 

What monitoring looks like when it works  

The teams managing PFAS regulatory complexity confidently are not necessarily the ones with the largest headcount. They are the ones that have moved from a task-based approach to treating compliance monitoring as a capability. 

Three observable differences define how that operates. 

Coverage mapped to product-relevant markets 

Most in-house monitoring concentrates on the jurisdictions the team has always tracked. But the gaps come from the places no one has thought to check. As PFAS regulation fragments across many more jurisdictions, that blind spot widens. Effective monitoring is built around where an organization’s products are sold, manufactured, and used, not around what the team already knows.  

Change detection is continuous  

Regulatory changes matter when they are published, not when the next review cycle happens to catch them. Teams with effective monitoring have visibility across consultations, draft publications, or final rules as they happen. That lead time converts a regulatory change into a manageable compliance decision rather than an urgent one.  

Interpretation built in  

Knowing that something changed is not the same as knowing what to do about it. A translated regulatory text is not enough. What compliance teams need is expert-authored analysis, giving them insight into what changed, what it means for a specific substance portfolio, and what action it requires.

Enhesa has spent more than 35 years building exactly that kind of capability, with 160+ in-house experts including toxicologists operating across 40+ countries. Half of the Global Fortune 500 rely on that expertise to stay ahead of regulatory change rather than respond to it.